Brief: Senzime Q1 EBITDA SEK -20.839 Million
22/04/2025 07:30
April 22 (Reuters) - Senzime AB (publ) SEZI.ST: Q1 SALES SEK 23.499 MILLION Q1 ADJUSTED GROSS MARGIN 65.9% Q1 OPERATING EXPENSES SEK 37.297 MILLION Q1 EBITDA SEK -20.839 MILLION PIPELINE FOR 2025 IS STRONG, AND WE CONTINUE TO SEE HIGH DEMAND Source text: ID:nMFN6K2C0m Further company coverage: SEZI.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Senzime AB (publ)
See all newsBrief: Senzime Tetragraph System Receives Anvisa Approval For Sale In Brazil
Brief: Senzime Secures Contract With U.S. Hospital
Brief: Senzime Gets Additional FDA Class II 510(K) Clearance For Tetragraph System
Brief: Senzime's TetraGraph System Contracted On Three GPO Agreements In U.S.
Sweden's Senzime Q1 sales dip on weak US markets, strong krona